Cepharanthine: An update of its mode of action, pharmacological properties and medical applications
C Bailly - Phytomedicine, 2019 - Elsevier
Background Cepharanthine (CEP) is a drug used in Japan since the 1950s to treat a
number of acute and chronic diseases, including treatment of leukopenia, snake bites …
number of acute and chronic diseases, including treatment of leukopenia, snake bites …
Cepharanthine: an update of its mode of action, pharmacological properties and medical applications.
C Bailly - 2019 - cabidigitallibrary.org
Background: Cepharanthine (CEP) is a drug used in Japan since the 1950s to treat a
number of acute and chronic diseases, including treatment of leukopenia, snake bites …
number of acute and chronic diseases, including treatment of leukopenia, snake bites …
[PDF][PDF] Cepharanthine: An update of its mode of action, pharmacological properties and medical applications
C Bailly - Phytomedicine, 2019 - academia.edu
Background: Cepharanthine (CEP) is a drug used in Japan since the 1950s to treat a
number of acute and chronic diseases, including treatment of leukopenia, snake bites …
number of acute and chronic diseases, including treatment of leukopenia, snake bites …
[HTML][HTML] Cepharanthine: An update of its mode of action, pharmacological properties and medical applications
C Bailly - Phytomedicine, 2019 - ncbi.nlm.nih.gov
Background Cepharanthine (CEP) is a drug used in Japan since the 1950s to treat a
number of acute and chronic diseases, including treatment of leukopenia, snake bites …
number of acute and chronic diseases, including treatment of leukopenia, snake bites …
[引用][C] Cepharanthine: An update of its mode of action, pharmacological properties and medical applications
C Bailly - 2019 - lilloa.univ-lille.fr
Cepharanthine: An update of its mode of action, pharmacological properties and medical
applications Toggle navigation English français Aide | Contact | À Propos | Ouvrir une …
applications Toggle navigation English français Aide | Contact | À Propos | Ouvrir une …
[引用][C] Cepharanthine: An update of its mode of action, pharmacological properties and medical applications
C Bailly - Phytomedicine, 2019 - cir.nii.ac.jp
Cepharanthine: An update of its mode of action, pharmacological properties and medical
applications | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
applications | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
[PDF][PDF] Cepharanthine: An update of its mode of action, pharmacological properties and medical applications
C Bailly - Phytomedicine, 2019 - hal.science
1. Origin, discovery and development of CEP 20 2. Anti-oxidative properties-Free radicals
scavenging 21 3. Anti-inflammatory properties-NFκB inhibition 22 4. Inhibition of drug efflux …
scavenging 21 3. Anti-inflammatory properties-NFκB inhibition 22 4. Inhibition of drug efflux …
Cepharanthine: An update of its mode of action, pharmacological properties and medical applications.
C Bailly - Phytomedicine: International Journal of Phytotherapy …, 2019 - europepmc.org
Background Cepharanthine (CEP) is a drug used in Japan since the 1950s to treat a
number of acute and chronic diseases, including treatment of leukopenia, snake bites …
number of acute and chronic diseases, including treatment of leukopenia, snake bites …
Cepharanthine: An update of its mode of action, pharmacological properties and medical applications
C Bailly - Phytomedicine: international journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Cepharanthine (CEP) is a drug used in Japan since the 1950s to treat a
number of acute and chronic diseases, including treatment of leukopenia, snake bites …
number of acute and chronic diseases, including treatment of leukopenia, snake bites …
[PDF][PDF] Cepharanthine: An update of its mode of action, pharmacological properties and medical applications
C Bailly - 2019 - hal.science
1. Origin, discovery and development of CEP 20 2. Anti-oxidative properties-Free radicals
scavenging 21 3. Anti-inflammatory properties-NFκB inhibition 22 4. Inhibition of drug efflux …
scavenging 21 3. Anti-inflammatory properties-NFκB inhibition 22 4. Inhibition of drug efflux …